Literature DB >> 23846285

Malondialdehyde and CA II autoantibody levels are elevated in children with undescended testes.

Ahmet Alver1, Mustafa İmamoğlu, Ahmet Menteşe, Ayşe Şentürk, Serap Samut Bülbül, Cemil Kahraman, Ayşegül Sümer.   

Abstract

PURPOSE: In the pathogenesis of sub-fertility/infertility and testicular cancer related to undescended testes, oxidative stress, inflammation and autoimmunity are important factors. Therefore, the present study was designed to determine serum oxidative stress markers and carbonic anhydrase (CA) II autoantibodies in boys with undescended testes (UDT), and to investigate the relationship between these parameters.
METHODS: Serum CA II autoantibody titers, malondialdehyde (MDA), ischemia modified albumin (IMA), protein carbonyl content and soluble CD40 ligand (sCD40L) levels were measured in 59 boys with UDT and 30 healthy subjects.
RESULTS: MDA levels were significantly higher in the UDT group compared with the control group (p = 0.003). There was no significant difference between serum IMA, sCD40L or protein carbonyl levels. CA II autoantibody titers in the UDT group were significantly higher compared with those of the control group (p = 0.048). A weak positive correlation was determined between anti-CA II antibody titers and MDA and IMA levels (p = 0.041, p = 0.005, respectively).
CONCLUSIONS: MDA is the most reliable and decisive biochemical marker displaying oxidative damage in undescended testes, and an autoimmune response may be triggered by oxidative stress against CA II during the UDT process.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23846285     DOI: 10.1007/s00345-013-1129-9

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  29 in total

Review 1.  Cryptorchidism: diagnosis, treatment, and long-term prognosis.

Authors:  Thomas F Kolon; Rakesh P Patel; Dale S Huff
Journal:  Urol Clin North Am       Date:  2004-08       Impact factor: 2.241

2.  Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin.

Authors:  D Roy; J Quiles; D C Gaze; P Collinson; J C Kaski; G F Baxter
Journal:  Heart       Date:  2006-01       Impact factor: 5.994

Review 3.  Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.

Authors:  Claudiu T Supuran
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

4.  Carbonic anhydrase II autoantibody and oxidative stress in rheumatoid arthritis.

Authors:  Ahmet Alver; Ayşe Şentürk; Haşim Çakirbay; Ahmet Menteşe; Ferhat Gökmen; E Edip Keha; Fahri Uçar
Journal:  Clin Biochem       Date:  2011-10-02       Impact factor: 3.281

5.  Elevated oxidative stress in erythrocytes due to a SOD1 deficiency causes anaemia and triggers autoantibody production.

Authors:  Yoshihito Iuchi; Futoshi Okada; Kunishige Onuma; Tadashi Onoda; Hironobu Asao; Masanobu Kobayashi; Junichi Fujii
Journal:  Biochem J       Date:  2007-03-01       Impact factor: 3.857

6.  Covalent attachment of 4-hydroxy-2-nonenal to erythrocyte proteins.

Authors:  K Uchida; Y Hasui; T Osawa
Journal:  J Biochem       Date:  1997-12       Impact factor: 3.387

7.  A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report.

Authors:  D Bar-Or; E Lau; J V Winkler
Journal:  J Emerg Med       Date:  2000-11       Impact factor: 1.484

8.  Induction of experimental autoimmune sialoadenitis by immunization of PL/J mice with carbonic anhydrase II.

Authors:  I Nishimori; T Bratanova; I Toshkov; T Caffrey; M Mogaki; Y Shibata; M A Hollingsworth
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

9.  Protein-bound 4-hydroxy-2-nonenal: an endogenous triggering antigen of antI-DNA response.

Authors:  Kazuyo Toyoda; Ritsuko Nagae; Mitsugu Akagawa; Kosuke Ishino; Takahiro Shibata; Sohei Ito; Noriyuki Shibata; Tomoko Yamamoto; Makio Kobayashi; Yoshinari Takasaki; Tsukasa Matsuda; Koji Uchida
Journal:  J Biol Chem       Date:  2007-06-22       Impact factor: 5.157

10.  Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation.

Authors:  Suleyman Turedi; Abdulkadir Gunduz; Ahmet Mentese; Bengu Dasdibi; Suleyman Caner Karahan; Aynur Sahin; Gamze Tuten; Muge Kopuz; Ahmet Alver
Journal:  Resuscitation       Date:  2009-07-05       Impact factor: 5.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.